THOUSAND OAKS, Calif., Sept. 20, 2023 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”) today announced that Peter Anastasiou, Chief Executive Officer, will present a corporate update at the following upcoming investor and industry conferences: Jefferies Cell & Genetic Medicine Summit…
